...
首页> 外文期刊>Analytical Biochemistry: An International Journal of Analytical and Preparative Methods >Enhancement of ovarian tumor classification by improved reproducibility in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of serum glycans
【24h】

Enhancement of ovarian tumor classification by improved reproducibility in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of serum glycans

机译:通过提高血清聚糖的基质辅助激光解吸/电离飞行时间质谱中的再现性来增强卵巢肿瘤分类

获取原文
获取原文并翻译 | 示例

摘要

The serum N-glycome is a promising source of biomarker discovery. Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS) profiling of serum N-glycans was attempted for differentiating borderline ovarian tumor from benign cases, for which a low data spread is essential. An experimental protocol using matrix-prespotted MALDI plates and fast vacuum drying of the loaded N-glycan samples was developed, thereby minimizing the intensity variations in the replicates to an average relative standard deviation (RSD) of 3.96% for the highest N-glycan peak (m/z 1485.53) of the Sigma-Aldrich serum standard. When applied to sera of ovarian tumors, this procedure exhibited an average RSD of 5.74% for m/z 1485.53 and of 7.28% for all MS peaks. This improved reproducibility combined with the OVA-Beyond ? screening software resulted in 75.1% and 79.4% correct classification for benign and borderline tumor samples, respectively, while the classification rates by the conventional ovarian tumor marker CA~(-1)25 were 54.4% and 53.1%, respectively. Both true positive rate and true negative rate fluctuated with small numbers of markers and converged as the number of markers increased. Cross-validations were performed in comparison with CA~(-1)25. These results suggest that our optimized process for MALDI-TOF MS of the serum glycome has a great potential for the screening of early stage ovarian cancer.
机译:血清N糖是生物标志物发现的有希望的来源。尝试使用血清N-聚糖的基质辅助激光解吸/电离飞行时间(MALDI-TOF)质谱(MS)谱分析来区分卵巢良性肿瘤与良性病例,对于这些病例,低数据传播至关重要。开发了使用基质预分散的MALDI板和快速真空干燥加载的N-聚糖样品的实验方案,从而将重复样品的强度变化最小化,以使最高N-聚糖峰的平均相对标准偏差(RSD)为3.96% (m / z 1485.53)的Sigma-Aldrich血清标准品。当应用于卵巢肿瘤血清时,此程序显示m / z 1485.53的平均RSD为5.74%,所有MS峰的平均RSD为7.28%。结合了OVA-Beyond™,提高了可重复性筛查软件对良性和边缘性肿瘤样品的正确分类率分别为75.1%和79.4%,而常规卵巢肿瘤标记物CA〜(-1)25的分类率分别为54.4%和53.1%。真正的阳性率和真正的阴性率都随少量标记而波动,并随着标记数的增加而收敛。与CA〜(-1)25进行交叉验证。这些结果表明,我们针对血清糖蛋白的MALDI-TOF MS的优化方法具有筛查早期卵巢癌的巨大潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号